A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plagueSPEAR, Abigail M; RANA, Rohini R; JENNER, Dominic C et al.Microbiology (Reading). 2012, Vol 158, pp 1593-1606, issn 1350-0872, 14 p., 6Article

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthraxALBRECHT, Mark T; HAN LI; GROEN, Herman et al.Infection and immunity. 2007, Vol 75, Num 11, pp 5425-5433, issn 0019-9567, 9 p.Article

Small protective fragments of the Yersinia pestis V antigenVERNAZZA, Claire; LINGARD, Bry; FLICK-SMITH, Helen C et al.Vaccine. 2009, Vol 27, Num 21, pp 2775-2780, issn 0264-410X, 6 p.Article

An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factorBAILLIE, Les W; HUWAR, Theresa B; ALTMANN, Danny M et al.Vaccine. 2010, Vol 28, Num 41, pp 6740-6748, issn 0264-410X, 9 p.Article

Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in miceFLICK-SMITH, Helen C; EYLES, Jim E; HEBDON, Richard et al.Infection and immunity. 2002, Vol 70, Num 4, pp 2022-2028, issn 0019-9567Article